BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16186628)

  • 1. The ubiquitin-proteasome pathway is necessary for maintenance of the postmitotic status of neurons.
    Staropoli JF; Abeliovich A
    J Mol Neurosci; 2005; 27(2):175-83. PubMed ID: 16186628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis.
    Tu Y; Chen C; Pan J; Xu J; Zhou ZG; Wang CY
    Int J Clin Exp Pathol; 2012; 5(8):726-38. PubMed ID: 23071855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system.
    Chen G; Wang Y; Garate M; Zhou J; Li G
    Oncogene; 2010 Mar; 29(10):1498-508. PubMed ID: 19935701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up-regulate iHSP70, following proteasomal inhibition.
    Rideout HJ; Lang-Rollin IC; Savalle M; Stefanis L
    J Neurochem; 2005 Jun; 93(5):1304-13. PubMed ID: 15934949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CUL-2 ubiquitin ligase containing three FEM proteins degrades TRA-1 to regulate C. elegans sex determination.
    Starostina NG; Lim JM; Schvarzstein M; Wells L; Spence AM; Kipreos ET
    Dev Cell; 2007 Jul; 13(1):127-39. PubMed ID: 17609115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the role of the ubiquitin-proteasome pathway in the regulation of apoptosis.
    Liu CH; Goldberg AL; Qiu XB
    Chang Gung Med J; 2007; 30(6):469-79. PubMed ID: 18350730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of the protein degradation pathway by the ubiquitin family: its implication in neurodegenerative diseases].
    Chiba T; Tanaka K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):976-8. PubMed ID: 16447778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin, proteasomes, and the aging brain.
    Gray DA; Tsirigotis M; Woulfe J
    Sci Aging Knowledge Environ; 2003 Aug; 2003(34):RE6. PubMed ID: 12944592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.
    Huh K; Zhou X; Hayakawa H; Cho JY; Libermann TA; Jin J; Harper JW; Munger K
    J Virol; 2007 Sep; 81(18):9737-47. PubMed ID: 17609271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity.
    Staropoli JF; McDermott C; Martinat C; Schulman B; Demireva E; Abeliovich A
    Neuron; 2003 Mar; 37(5):735-49. PubMed ID: 12628165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.
    Hegde AN; Upadhya SC
    Biochim Biophys Acta; 2011 Feb; 1809(2):128-40. PubMed ID: 20674814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and deregulation of E2F1 in postmitotic neurons differentiated from embryonal carcinoma P19 cells.
    Azuma-Hara M; Taniura H; Uetsuki T; Niinobe M; Yoshikawa K
    Exp Cell Res; 1999 Sep; 251(2):442-51. PubMed ID: 10471329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recessive Parkinson's disease.
    Kubo S; Hattori N; Mizuno Y
    Mov Disord; 2006 Jul; 21(7):885-93. PubMed ID: 16615060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uraemic serum induces dysfunction of vascular endothelial cells: role of ubiquitin-proteasome pathway.
    Feng B; Zhang YQ; Mu J; Yuan FH; Ye ZL; Qi W; Guo YH; Zeng W; Luo ZF
    Exp Physiol; 2011 Aug; 96(8):801-15. PubMed ID: 21602294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative effects of the ubiquitin-proteasome pathway on glucocorticoid receptor down-regulation and transactivation are mediated by CHIP, an E3 ligase.
    Wang X; DeFranco DB
    Mol Endocrinol; 2005 Jun; 19(6):1474-82. PubMed ID: 15761032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
    McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
    Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
    Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
    Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-proteasome pathway and synaptic plasticity.
    Hegde AN
    Learn Mem; 2010 Jul; 17(7):314-27. PubMed ID: 20566674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.